S4 E2: Gestational Diabetes, CVD risk & modifiable factors; roflumilast for psoriasis; bronchodilators for non-COPD smoking symptoms

NB Hot Topics Podcast

English - September 30, 2022 10:00 - 20 minutes - 13.8 MB
Education Health & Fitness Medicine education medicine general practice health hot topics gp update nurse Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: S4 E1: Supplements + sweeteners aren't good for your health, autoimmune disease & CVD risk, statin & muscle pain, open source diabetes

Next Episode: S4 E3: Pension Song #1; BP meds at night?; CVD screening; "Future of General Practice" report; patient record access

Welcome to the new Hot Topics podcast from NB Medical with Dr Neal Tucker. After a whirlwind week where general practice has been populistically politicised on all sides, in this episode we stay on safer ground and look at new research.

The BMJ highlights the future risk of cardio- and cerebrovascular disease after gestational diabetes, even without overt diabetes, but offers some good news regarding the optimisation of risk factors. JAMA introduces roflumilast for chronic psoriasis, as a cream, not a tablet. And the NEJM explores whether there is a role for bronchodilators in people with COPD who don't have COPD - symptomatic smokers with preserved lung function.

References

Best research title of the podcast award
BMJ GDM and CVD risk
BMJ GDM and modifiable risk factors
JAMA Roflumilast for psoriasis
NEJM Bronchodilators for smoking Sx with preserved lung function